1. Karaaðaç H. Akut Ýntestinal Ýskemi Erken Tanýsýnda
Serum IL-1β, IL-6,TNFα ve Lökosit ölçümlerinin deðerlendirilmesi. Uzmanlýk Tezi, Ankara 2002.
2. Acosta S, Ogren M, Sternby NH, Bergqvist D, Bjorck M.
Incidence of acute thromboembolic occlusion of the
superior mesenteric artery--a population-based study. Eur
J Vasc Endovasc Surg 2004; 27: 145-150.
3. Schoots IG, Koffeman GI, Legemate DA, Levi M, van
Gulik TM. Systematic review of survival after acute
mesenteric ischaemia according to disease aetiology. Br J
Surg 2004; 91: 17-27.
4. Brandt LJ, Boley SJ. AGA technical review on intestinal
ischemia. American Gastrointestinal Association. Gastroenterology 2000; 118: 954-968.
5. Sreenarasimhaiah J. Diagnosis and management of intestinal ischaemic disorders. Br Med J 2003; 326: 1372-1376.
6. Cleveland TJ, Nawaz S, Gaines PA. Mesenteric arterial
ischaemia: diagnosis and therapeutic options. Vasc Med
2002; 7: 311-321.
7. Graeber GM, Cafferty PJ, Wolf RE, Harmon JW. An
analysis of creatine phosphokinase in the mucosa and the
muscularis of the gastrointestinal tract. J Surg Res 1984;
37: 376-382.
8. Graeber GM, Wolf RE, Harmon JW. Serum creatine
kinase and alkaline phosphatase in experimental small
bowel infarction. J Surg Res 1984; 37: 25-32.
9. Marks WH, Salvino C, Newell K, Wider M, Marks C.
Circulating concentrations of porcine ileal peptide but not
hexosaminidase are elevated following 1 hr of mesenteric
ischemia. J Surg Res 1988; 45: 134-139.
10. Thompson JS, Bragg LE, West WW. Serum enzyme levels during intestinal ischemia. Ann Surg 1990; 211: 369-
373.
11. Shenkar R, Abraham E. Effects of hemorrhage on cytokine gene transcription. Lymphokine Cytokine Res 1993;
12: 237-247.
12. Shenkar R, Chang YH, Abraham E. Cytokine expression
in Peyer's patches following hemorrhage and resuscitation. Shock 1994; 1: 25-30.
13. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel
SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990; 212: 694-700.
14. Mester M, Tompkins RG, Gelfand JA, Dinarello CA,
Burke JF, Clark BD. Intestinal production of interleukin-
1 alpha during endotoxemia in the mouse. J Surg Res
1993; 54: 584-591.
15. Olfert ED, Cross MB, William A. Hematology median
values and ranges. Canadian Council on Animal Care,
Guide to the Care and Use of Experimental Animals.
Ontario, Canada: 2nd ed. Vol 1. 1993.
16. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN.
Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch
Surg 1970; 101: 478-483.
17. Edwards MS, Cherr GS, Craven TE, et al. Acute occlusive
mesenteric ischemia: surgical management and outcomes.
Ann Vasc Surg 2003; 17: 72-79.
18. Bingol H, Zeybek N, Cingoz F, Yilmaz AT, Tatar H, Sen
D. Surgical therapy for acute superior mesenteric artery
embolism. Am J Surg 2004; 188: 68-70.Cilt 49 · Sayý 4 · Gülhane TD IL-1, IL-6 and TNFα in acute mesenteric ischemia · 221
19. Lefkovitz Z, Cappell MS, Lookstein R, Mitty HA, Gerard
PS. Radiologic diagnosis and treatment of gastrointestinal
hemorrhage and ischemia. Med Clin North Am 2002; 86:
1357-1399.
20. Greenwald DA, Brandt LJ, Reinus JF. Ischemic bowel
disease in the elderly. Gastroenterol Clin North Am 2001;
30: 445-473.
21. Hunter GC, Guernsey JM. Mesenteric ischemia. Med
Clin North Am 1988; 72: 1091-1115.
22. Pullicino EA, Carli F, Poole S, Rafferty B, Malik ST, Elia
M. The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF)
and the acute phase response to elective surgery and accidental injury. Lymphokine Res 1990; 9: 231-238.
23. Ala Y, Palluy O, Favero J, Bonne C, Modat G, Dornand J.
Hypoxia/reoxygenation stimulates endothelial cells to
promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agents Actions 1992; 37:
134-139.
24. Cicco NA, Lindemann A, Content J, et al. Inducible production of interleukin-6 by human polymorphonuclear
neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood
1990; 75: 2049-2052.
25. Meyer TA, Noguchi Y, Ogle CK, et al. Endotoxin stimulates interleukin-6 production in intestinal epithelial cells.
A synergistic effect with prostaglandin E2. Arch Surg
1994; 129: 1290-1294.
26. Van Damme J, Opdenakker G, Simpson RJ, et al. Identification of the human 26-kD protein, interferon beta 2
(IFN-beta 2), as a B cell hybridoma/plasmacytoma growth
factor induced by interleukin 1 and tumor necrosis factor.
J Exp Med 1987; 165: 914-919.
27. Bishop RF, Allcock EA. Bacterial flora of the small intestine in acute intestinal obstruction. Br Med J 1960; 5175:
766-770.
28. Michalsky MP, Deitch EA, Ding J, Lu Q, Huang Q.
Interleukin-6 and tumor necrosis factor production in an
enterocyte cell model (Caco-2) during exposure to
Escherichia coli. Shock 1997; 7: 139-146.
29. Gaffin SL, Gathiram P, Wells MT, Brock-Utne JG. Effect
of corticosteroid prophylaxis on lipopolysaccharide levels
associated with intestinal ischemia in cats. Crit Care Med
1986; 14: 889-891.
30. Roscher R, Oettinger W, Beger HG. Bacterial microflora,
endogenous endotoxin, and prostaglandins in small bowel
obstruction. Am J Surg 1988; 155: 348-355.
31. Moore JN, White NA, Berg JN, Trim CM, Garner HE.
Endotoxemia following experimental intestinal strangulation obstruction in ponies. Can J Comp Med 1981; 45:
330-332.
32. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ,
Burger CD. Acute mesenteric ischemia: a clinical review.
Arch Intern Med 2004; 164: 1054-1062.
Thank you for copying data from http://www.arastirmax.com